Diffusing capacity: Difference between revisions

Revision as of 21:03, 1 September 2007

Revision as of 21:06, 1 September 2007

Line 21:

==Interpretation==

The diffusing capacity (DLCO) is a test of the integrity of the alveolar-capillary surface area for gas transfer. It may be reduced in disorders that damage the alveolar walls (septa) such as emphysema. The DLCO is also reduced in disorders that thicken or damage the internal structure of the alveolar walls such as pulmonary fibrosis. Because the transfer of CO depends upon how much blood is traversing the lung, the DLCO can be reduced due to anemia. Thus, someSome laboratories adjust or correct the DLCO to take into account the effect of anemia. Disorders of the pulmonary blood vessels such as thromboembolic disease or pulmonary hypertension also reduce the diffusing capacity. Cigarette smokers tend to have lower DLCO, which is partly due to damage to the lungs and partly due to the retention of carbon monoxide from the cigarettes. For these reasons, the DLCO is a sensitive test for disorders of the lung, but does not point toward a specific diagnosis.

==External links==